Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Mutations in the spike protein affect drug binding and effectiveness.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Caregiver burden and patient health issues significantly affect emotional distress in both COPD patients and their caregivers.

COVID-19 may harm male fertility and damage the reproductive system.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Possible link between androgens and COVID-19 severity; more research needed.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Breathing in fine particles or Asian dust short-term doesn't affect schoolchildren's skin symptoms.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Most patients experience temporary hair loss after ECMO, but it usually grows back within 6 months without treatment.

Choline and biotin are important for liver health and preventing certain deficiencies in animals, and more research is needed to understand their benefits in humans.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

More research is needed to improve telemedicine in primary care.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Zinc helps reduce the severity of depression.

Camels in South Iraq were cured of skin infections with antibiotics and supplements.

Red and infrared light therapy improves hair growth in balding patients.

A toddler who accidentally swallowed hair growth medicine experienced serious heart-related side effects but recovered after hospital treatment.